Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2022 | Evaluating the feasibility of telemedicine in movement disorders care

Since the beginning of the COVID-19 pandemic, the use of telemedicine has increased, as well as the studies evaluating its feasibility and utility. Esther Cubo Delgado, MD, PhD, FAAN, Hospital General Yague, Burgos, Spain, discusses the benefits and challenges of telemedicine in Parkinson’s disease care. Telemedicine can provide the opportunity for every patient to receive care from movement disorders specialists, regardless of social or economic status, therefore, promoting health equity. However, it is also important to recognize that telemedicine may increase disparities in health care access for vulnerable populations with limited digital literacy or access. An ongoing initiative is investigating the feasibility of telemedicine outcomes around the globe, and preliminary data has shown positive results with a low dropout of patients under the telemedicine management program. This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.